Mealey's (August 22, 2022, 1:16 PM EDT) -- WASHINGTON, D.C. —The Federal Circuit U.S. Court of Appeals on Aug. 18 left intact a Delaware federal judge’s determination that an abbreviated new drug application (ANDA) for generic Vasostrict would not infringe two patents associated with the blood pressure medication....